blog navigation

blog posts

  • New drug stalls estrogen receptor-positive cancer cells and shrinks tumors

    Researchers have developed a new drug that kills estrogen receptor-positive cancers in mice. The team, from left, includes M.D./Ph.D students Neal Andruska, Lily Mahapatra and Mathew Cherian; graduate student Xiaobin Zheng; food science and human nutrition professor William Helferich; research scientist Chengjian Mao; and biochemistry professor David Shapiro.

    Researchers have developed a new drug that kills estrogen receptor-positive cancers in mice. The team, from left, includes M.D./Ph.D students Neal Andruska, Lily Mahapatra and Mathew Cherian; graduate student Xiaobin Zheng; food science and human nutrition professor William Helferich; research scientist Chengjian Mao; and biochemistry professor David Shapiro.

    Photo by L. Brian Stauffer

    Images

blog posts

  • To reach David Shapiro, call 217-333-1788; email djshapir@illinois.edu.

    The paper, “An Estrogen Receptor Alpha Inhibitor Activates the Unfolded Protein Response and Induces Tumor Regression,” is available online and from the News Bureau.